Literature DB >> 3815402

Phase II clinical trial of tricyclic nucleoside phosphate for advanced colorectal cancer.

M J O'Connell, J Rubin, R G Hahn, L K Kvols, C G Moertel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3815402

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  3 in total

1.  Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT.

Authors:  Christopher R Garrett; Domenico Coppola; Robert M Wenham; Christopher L Cubitt; Anthony M Neuger; Timothy J Frost; Richard M Lush; Daniel M Sullivan; Jin Q Cheng; Saïd M Sebti
Journal:  Invest New Drugs       Date:  2010-07-20       Impact factor: 3.850

Review 2.  Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations.

Authors:  Jaclyn LoPiccolo; Gideon M Blumenthal; Wendy B Bernstein; Phillip A Dennis
Journal:  Drug Resist Updat       Date:  2007-12-31       Impact factor: 18.500

3.  An Expedient Total Synthesis of Triciribine.

Authors:  Chen Hu; Zhizhong Ruan; Haixin Ding; Yirong Zhou; Qiang Xiao
Journal:  Molecules       Date:  2017-04-17       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.